Vasopressin and disruption of calcium signalling in polycystic kidney disease
Vasopressin and disruption of calcium signalling in polycystic kidney disease is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Vasopressin and disruption of calcium signalling in polycystic kidney disease have?
Vasopressin and disruption of calcium signalling in polycystic kidney disease has 140 citations in the OpenAlex counts ScholarIQ stores.
When was Vasopressin and disruption of calcium signalling in polycystic kidney disease published?
Vasopressin and disruption of calcium signalling in polycystic kidney disease has 2015 year in the ScholarIQ index.
What is the open-access status of Vasopressin and disruption of calcium signalling in polycystic kidney disease?
Vasopressin and disruption of calcium signalling in polycystic kidney disease has green oa status in the ScholarIQ index.
What is the DOI of Vasopressin and disruption of calcium signalling in polycystic kidney disease?
The DOI for Vasopressin and disruption of calcium signalling in polycystic kidney disease is on the source record.
What is the PMID of Vasopressin and disruption of calcium signalling in polycystic kidney disease?
The PMID for Vasopressin and disruption of calcium signalling in polycystic kidney disease is on the source record.
What is the OpenAlex record for Vasopressin and disruption of calcium signalling in polycystic kidney disease?
The OpenAlex for Vasopressin and disruption of calcium signalling in polycystic kidney disease is on the source record.